Share on LinkedInShare on LinkedIn

ARTICLE · 29 SEPTEMBER 2015

FDA Issues Emergency Use Authorization For MERS-Cov Detection Device

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

In the September 1, 2015, Federal Register, FDA announced the issuance of an EUA for an in vitro diagnostic device for detection of Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

United StatesFood, Drugs, Healthcare, Life Sciences

In the September 1, 2015, Federal Register, FDA announced the issuance of an EUA for an in vitro diagnostic device for detection of Middle East Respiratory Syndrome Coronavirus (MERS-CoV). FDA issued this authorization under the FDCA, as requested by altona Diagnostics GmbH.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from